Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer research has been reported by scientists at Creighton University, Medical Department
February 19th, 2009
According to a study from the United States, "The isothiocyanates (ITCs) have long been known to possess chemopreventive activities for a variety of neoplasms including breast cancer, but the molecular mechanism by which ITCs prevent breast cancer development has not been established. In this study, we investigated the effects of benzyl and phenethyl isothiocyanate (BITC and PETTC) on the estrogen-stimulated growth of estrogen receptor alpha (ER alpha)positive breast cancer MCF7 and T-47D cells." "BTTC and PEITC inhibited estrogen-stimulated cell growth and reduced the expression levels of ER alpha in MCF7 and T-47D cells in a dose- and time-dependent and reversible...
Source: Women's Health Weekly (2009-02-19)
|
